首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice
【24h】

Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice

机译:抑制小鼠乳腺肿瘤转移的偏头痛素的合成类似物

获取原文
获取原文并翻译 | 示例
       

摘要

Tumor metastasis is the most common cause of death in cancer patients. Here, we show that two, fully synthetic migrastatin analogues, core macroketone and core macrolactam, are potent inhibitors of metastasis in a murine breast tumor model. Administration of these readily accessible compounds nearly completely inhibits lung metastasis of highly metastatic mammary carcinoma cells. Treatment of tumor cells with core macroketone and core macrolactam blocks Rac activation, lamellipodia formation, and cell migration, suggesting that these chemical compounds interfere with the invasion step of the metastatic process. These compounds also inhibit the migration of human metastatic breast cancer cells, prostate cancer cells, and colon cancer cells but not normal mammary-gland epithelial cells, fibroblasts, and leukocytes. These data demonstrate that the macroketone and macrolactam core structures are specific small-molecule inhibitors of tumor metastasis. These compounds or their analogues could potentially be used in cancer-therapy strategies.
机译:肿瘤转移是癌症患者最常见的死亡原因。在这里,我们显示了两种完全合成的偏头痛他汀类似物,核心大酮和核心大内酰胺,是小鼠乳腺肿瘤模型中转移的有效抑制剂。施用这些容易获得的化合物几乎完全抑制了高度转移性乳腺癌细胞的肺转移。用核心大酮和核心大内酰胺治疗肿瘤细胞会阻止Rac活化,片状脂蛋白形成和细胞迁移,这表明这些化合物干扰了转移过程的侵袭步骤。这些化合物还抑制人转移性乳腺癌细胞,前列腺癌细胞和结肠癌细胞的迁移,但不抑制正常的乳腺上皮细胞,成纤维细胞和白细胞的迁移。这些数据证明大酮和大内酰胺核心结构是肿瘤转移的特定小分子抑制剂。这些化合物或其类似物可潜在地用于癌症治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号